Loading clinical trials...
Loading clinical trials...
Genetic, Biochemical and Functional Markers of Cardiovascular Risk in Patients With Premature Coronary Artery Disease and Treatment Options
Conditions
Interventions
Alirocumab
Evolocumab
+1 more
Locations
1
Slovenia
University Medical Centre Ljubljana-Department of Vascular diseases and dept. of Cardiology
Ljubljana, Slovenia
Start Date
November 10, 2020
Primary Completion Date
June 30, 2021
Completion Date
October 1, 2021
Last Updated
November 3, 2020
NCT07436429
NCT07429227
NCT01311323
NCT06543082
NCT06535568
NCT07032389
Andreja Rehberger Likozar, MD
CONTACT
+38615228012rehbergerandreja@gmail.com, andreja.rehbergerlikozar@kclj.siLead Sponsor
University Medical Centre Ljubljana
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions